american society of anesthesiologists glp-1 RA medications and Anesthesia Considerations Unified Multi-society Guidance American Society of Anesthesiologists Consensus-Based – A narrative review of glucagon-like

What causes this decline

When to Consider Testing Testing may be useful: Before starting a GLP-1 medicine After a meaningful treatment change When diabetes goals are not being met When persistent gastrointestinal symptoms develop When food or fluid intake has significantly decreased When kidney or liver risk is already present When a prior result was abnormal When a healthcare provider recommends follow-up Testing frequency should be based on individual risk rather than an automatic monthly or quarterly panel for everyone

blinded dermatologist assessment and silicon replica analysis provided objective measurement

Each dose increase brings a renewed wave of appetite suppression

COAs available pre-purchase

Image from the paper of Araj et